Skip to site menu Skip to page content

Daily Newsletter

17 August 2023

Daily Newsletter

17 August 2023

NHS starts campaign to educate public about heart attacks

The campaign aims to raise awareness about the early signs of a heart attack and encourage people to call 999.

August 16 2023

The NHS in the UK has launched a campaign to help the public spot heart attacks and increase the chances of survival.

This campaign aims to raise awareness about the early signs of a heart attack and encourage people to call 999 when experiencing these symptoms.

It comes amid the rebound in heart attack admission numbers to pre-pandemic levels.

According to NHS, England recorded over 84,000 hospital heart attack admissions in 2021/22, which is more than 7,000 higher than the prior year.

Early action can save lives, as most heart muscle damage occurs within the first few hours of a heart attack, stated NHS.

The campaign includes an NHS advertisement encouraging individuals to call 999 if they have symptoms such as chest tightness, sweating, and a sense of uneasiness.

It looks to particularly make women aware of the matter, for whom heart attack risks are affected by factors such as menopause.

The focus of the initiative is to educate people about the importance of seeking immediate medical attention, which is expected to reduce fatalities.

Health minister Lord Markham said: “A heart attack is a medical emergency, and recognising the symptoms can be the difference between life or death.

“This brilliant campaign shows what to look out for, and we urge people to call 999 immediately if they notice themselves, or others, experiencing the warning signs.

“Cardiovascular disease is the second biggest killer in England, and this campaign builds on the work we’re doing to cut NHS waiting lists by tackling this condition early – including by rolling out a new digital NHS health check which could prevent hundreds more strokes and heart attacks.”

Digital transformation of the healthcare industry is driving the demand and development for precision and personalized medicine

Per GlobalData estimates, the precision and personalized medicine market is expected to achieve a CAGR of more than 43% between 2022 and 2029. The digital transformation of the healthcare industry is driving the market demand. For example, advances in biomarker testing with NGS are improving patient selection, use of AI in identifying trends in big datasets is accelerating the time from drug discovery to commercialization, and the use of Industry 4.0 technologies is improving the quality and efficiency of manufacturing complex drugs such as cell and gene therapies.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close